Tracer library / [11C]PS13

Structure of PS13 (unlabelled parent compound, from PubChem) — Unlabelled parent compoundPubChem CID 22341583

[11C]PS13

Also written as [11C]PS13; [C-11]PS13

Radionuclide: C-11 t½ 20.36 min
Modality: PET
Production route: —
Stage: Clinical research
Syntheses indexed: 1

Neuroinflammation Gynaecological cancer Preclinical only, no clinical indication yet Receptor expression phenotyping

What it is

Compound class: 1,5-diaryl-1H-1,2,4-triazole
Target / mechanism: Cyclooxygenase-1 (COX-1) PMID 42083927
Clinical application: Healthy volunteers; neuroinflammation research PMID 32399622
Theranostic pair: —

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
TracerMaker Scansys Laboratorieteknik	—	—	—	—	—	42140884 2026 J Labelled Comp Radiopharm a fully automated TracerMaker radiosynthesizer for routine production of multiple 11C-labeled PET tracers

Need this precursor?We can point you to suppliers for [11C]PS13, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph: not verified No Ph. Eur. check is recorded for this entry.
USP monograph: not verified No USP check is recorded for this entry.

AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity

How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [11C]PS13.

Get in touch

Notes

Added from reverse module search (stage 6); 2 article(s) with C-11. | Stage 30 (2026-09-18): Stage was 'first-in-human'; normalised to 'Clinical research', original wording kept here.